Risk of Thromboembolic Events Following COVID-19 Diagnosis Without Hospitalization

Journal of the American Board of Family Medicine: JABFM

article

Katherine Schreck¹  Caroline Carlin¹  Jason Ricco¹ 

[1] Department of Family Medicine and Community Health, University of Minnesota Medical School

关键词: Anticoagulants;    COVID-19;    Incidence;    Retrospective Studies;    SARS-CoV-2;    Urban Health;    Venous Thromboembolism;   

DOI  :  10.3122/jabfm.2022.220180R2

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

Introduction: Current research shows no increased risk of thromboembolic events with mild COVID-19 but does not account for comorbidities. The aim of this study was to examine the incidence of thromboembolic events, including pulmonary embolism, cerebral infarction, and deep vein thrombosis, in nonhospitalized patients diagnosed with COVID-19 while accounting for comorbidities such as diabetes, asthma, COPD and cancer.Methods: We completed a large retrospective observational analysis of adult patients within a large urban health system.Results: Using a logit framework (with and without propensity score weighting), there was no increased risk of thromboembolic events among patients positive for SARS-CoV-2 who did not require hospitalization for COVID-19.Conclusion: This data suggest prophylactic anticoagulation is likely not warranted in the outpatient setting.

【 授权许可】

CC BY